Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 8/2009

01.12.2009 | Letter to the Editors

Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3–6 February 2009

verfasst von: James Bowes Kirkbride, Linda Scoriels

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

In this review, we present the main findings of the 6th Symposium for the Search for the Causes of Schizophrenia, which took place between 3 and 6 February 2009, in Sao Paulo, Brazil. In a few short years, the landscape of the causes of schizophrenia has changed dramatically. The flat and featureless epidemiological horizon has developed undulating contours, which promise new avenues for research, particularly if we are able to integrate such findings with tantalising new findings from genetics as novel methods for identifying genuine sites of genetic risk emerge. The Search highlighted and fostered the emerging acknowledgement that we will need to integrate knowledge across traditionally disparate disciplines in psychiatry in order to develop complex, testable hypotheses in the search for the causes of schizophrenia. Such challenges are beginning to be addressed. From epidemiology, gene–environment studies are becoming more sophisticated, while neuroscience is increasingly concerned about social organisation and how social factors impinge upon biological pathways to potentially lead to psychosis. Tantalising new insights from genome-wide association studies offer new clues about rare genetic mutations, which have large effect sizes for schizophrenia, including copy number variants and de novo mutations. It is only through forums such as the 6th Symposium for the Search for the Causes of Schizophrenia that the seeds of integrated collaborations across disciplines can be sown to address the complex polyfactorial basis of schizophrenia.
Literatur
1.
Zurück zum Zitat Allardyce J, Gilmour H, Atkinson J et al (2005) Social fragmentation, deprivation and urbanicity: relation to first-admission rates for psychoses. Br J Psychiatry 187(5):401–406CrossRefPubMed Allardyce J, Gilmour H, Atkinson J et al (2005) Social fragmentation, deprivation and urbanicity: relation to first-admission rates for psychoses. Br J Psychiatry 187(5):401–406CrossRefPubMed
2.
Zurück zum Zitat Allardyce J, McCreadie R, Morrison G et al (2007) Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Soc Psychiatry Psychiatr Epidemiol 42(6):429–437CrossRefPubMed Allardyce J, McCreadie R, Morrison G et al (2007) Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Soc Psychiatry Psychiatr Epidemiol 42(6):429–437CrossRefPubMed
3.
Zurück zum Zitat Boydell J, van Os J, McKenzie K et al (2001) Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. Br Med J 323(7325):1336–1338CrossRef Boydell J, van Os J, McKenzie K et al (2001) Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. Br Med J 323(7325):1336–1338CrossRef
4.
Zurück zum Zitat Brewer WJ, Wood SJ, Phillips LJ et al (2006) Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull 32(3):538–555CrossRefPubMed Brewer WJ, Wood SJ, Phillips LJ et al (2006) Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull 32(3):538–555CrossRefPubMed
5.
Zurück zum Zitat Cameron SC, Deanna MB, Robert WB et al (2008) Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the cognitive neuroscience treatment research to improve cognition in schizophrenia initiative. Biol Psychiatry 64(1):4–10CrossRef Cameron SC, Deanna MB, Robert WB et al (2008) Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the cognitive neuroscience treatment research to improve cognition in schizophrenia initiative. Biol Psychiatry 64(1):4–10CrossRef
6.
Zurück zum Zitat Cannon TD, Cadenhead K, Cornblatt B et al (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65(1):28–37CrossRefPubMed Cannon TD, Cadenhead K, Cornblatt B et al (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65(1):28–37CrossRefPubMed
7.
Zurück zum Zitat Cantor-Graae E, Selten J-P (2005) Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162(1):12–24CrossRefPubMed Cantor-Graae E, Selten J-P (2005) Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162(1):12–24CrossRefPubMed
8.
Zurück zum Zitat Consortium IS (2008) Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210):237–241CrossRef Consortium IS (2008) Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210):237–241CrossRef
9.
Zurück zum Zitat Crow TJ (2008) Craddock & Owen vs Kraepelin: 85 years late, mesmerised by “polygenes”. Schizophr Res 103(1–3):156–160CrossRefPubMed Crow TJ (2008) Craddock & Owen vs Kraepelin: 85 years late, mesmerised by “polygenes”. Schizophr Res 103(1–3):156–160CrossRefPubMed
10.
Zurück zum Zitat Crow TJ (2008) The emperors of the schizophrenia polygene have no clothes. Psychol Med 38(12):1681–1685CrossRefPubMed Crow TJ (2008) The emperors of the schizophrenia polygene have no clothes. Psychol Med 38(12):1681–1685CrossRefPubMed
11.
Zurück zum Zitat Di Forti M, Lappin JM, Murray RM (2007) Risk factors for schizophrenia—all roads lead to dopamine. Eur Neuropsychopharmacol 17(Suppl 2):S101–S107CrossRefPubMed Di Forti M, Lappin JM, Murray RM (2007) Risk factors for schizophrenia—all roads lead to dopamine. Eur Neuropsychopharmacol 17(Suppl 2):S101–S107CrossRefPubMed
12.
Zurück zum Zitat Ebner F, Tepest R, Dani I et al (2008) The hippocampus in families with schizophrenia in relation to obstetric complications. Schizophr Res 104(1–3):71–78CrossRefPubMed Ebner F, Tepest R, Dani I et al (2008) The hippocampus in families with schizophrenia in relation to obstetric complications. Schizophr Res 104(1–3):71–78CrossRefPubMed
13.
Zurück zum Zitat Freeman D, Gittins M, Pugh K et al (2008) What makes one person paranoid and another person anxious? The differential prediction of social anxiety and persecutory ideation in an experimental situation. Psychol Med 38(8):1121–1132CrossRefPubMed Freeman D, Gittins M, Pugh K et al (2008) What makes one person paranoid and another person anxious? The differential prediction of social anxiety and persecutory ideation in an experimental situation. Psychol Med 38(8):1121–1132CrossRefPubMed
14.
Zurück zum Zitat Gattaz WF, Hafner H (eds) (2004) Search for the cause of schizophrenia. Steikopff-verlag, Darmstadt Gattaz WF, Hafner H (eds) (2004) Search for the cause of schizophrenia. Steikopff-verlag, Darmstadt
15.
Zurück zum Zitat Gregório SP, Sallet PC, Do K-A et al (2009) Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Res 165(1–2):1–9CrossRefPubMed Gregório SP, Sallet PC, Do K-A et al (2009) Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Res 165(1–2):1–9CrossRefPubMed
16.
Zurück zum Zitat Hall FS, Wilkinson LS, Humby T et al (1999) Maternal deprivation of neonatal rats produces enduring changes in dopamine function. Synapse 32(1):37–43CrossRefPubMed Hall FS, Wilkinson LS, Humby T et al (1999) Maternal deprivation of neonatal rats produces enduring changes in dopamine function. Synapse 32(1):37–43CrossRefPubMed
17.
Zurück zum Zitat Heijmans BT, Tobi EW, Stein AD et al (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci 105(44):17046–17049CrossRefPubMed Heijmans BT, Tobi EW, Stein AD et al (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci 105(44):17046–17049CrossRefPubMed
18.
Zurück zum Zitat Homayoun H, Moghaddam B (2008) Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs. Proc Natl Acad Sci 105(46):18041–18046CrossRefPubMed Homayoun H, Moghaddam B (2008) Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs. Proc Natl Acad Sci 105(46):18041–18046CrossRefPubMed
19.
Zurück zum Zitat Huttunen J, Heinimaa M, Svirskis T et al (2008) Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol Psychiatry 63(1):114–117CrossRefPubMed Huttunen J, Heinimaa M, Svirskis T et al (2008) Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol Psychiatry 63(1):114–117CrossRefPubMed
20.
Zurück zum Zitat Jones PB, Barnes TRE, Davies L et al (2006) Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 63(10):1079–1087CrossRefPubMed Jones PB, Barnes TRE, Davies L et al (2006) Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 63(10):1079–1087CrossRefPubMed
21.
Zurück zum Zitat Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160(1):13–23CrossRefPubMed Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160(1):13–23CrossRefPubMed
22.
Zurück zum Zitat Kirkbride J, Boydell J, Ploubidis G et al (2008) Testing the association between the incidence of schizophrenia and social capital in an urban area. Psychol Med 38(8):1083–1094CrossRefPubMed Kirkbride J, Boydell J, Ploubidis G et al (2008) Testing the association between the incidence of schizophrenia and social capital in an urban area. Psychol Med 38(8):1083–1094CrossRefPubMed
23.
Zurück zum Zitat Kirkbride JB, Fearon P, Morgan C et al (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-Center ÆSOP study. Arch Gen Psychiatry 63(3):250–258CrossRefPubMed Kirkbride JB, Fearon P, Morgan C et al (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-Center ÆSOP study. Arch Gen Psychiatry 63(3):250–258CrossRefPubMed
24.
Zurück zum Zitat Lieberman JA, Stroup TS, McEvoy JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209–1223CrossRefPubMed Lieberman JA, Stroup TS, McEvoy JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209–1223CrossRefPubMed
25.
Zurück zum Zitat Linscott RJ, Allardyce J, van Os J (2009) Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophr Bull (in press) Linscott RJ, Allardyce J, van Os J (2009) Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophr Bull (in press)
26.
Zurück zum Zitat Lodge DJ, Grace AA (2008) Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization. J Neurosci 28(31):7876–7882CrossRefPubMed Lodge DJ, Grace AA (2008) Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization. J Neurosci 28(31):7876–7882CrossRefPubMed
27.
28.
Zurück zum Zitat Martins-de-Souza D, Gattaz W, Schmitt A et al (2009a) Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259(3):151–163 Martins-de-Souza D, Gattaz W, Schmitt A et al (2009a) Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259(3):151–163
29.
Zurück zum Zitat Martins-de-Souza D, Gattaz W, Schmitt A et al (2009) Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm 116(3):275–289CrossRefPubMed Martins-de-Souza D, Gattaz W, Schmitt A et al (2009) Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm 116(3):275–289CrossRefPubMed
30.
Zurück zum Zitat Martins-de-Souza D, Gattaz WF, Schmitt A et al (2008) Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res (Epub ahead of print) Martins-de-Souza D, Gattaz WF, Schmitt A et al (2008) Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res (Epub ahead of print)
31.
Zurück zum Zitat McGrath J, Saha S, Welham J et al (2004) A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2:13CrossRefPubMed McGrath J, Saha S, Welham J et al (2004) A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2:13CrossRefPubMed
32.
Zurück zum Zitat McGrath JJ (2007) The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry 64(1):14–16CrossRefPubMed McGrath JJ (2007) The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry 64(1):14–16CrossRefPubMed
33.
Zurück zum Zitat McGrath JJ, Susser ES (2009) New directions in the epidemiology of schizophrenia. Med J Aust 190(4):S7–S9PubMed McGrath JJ, Susser ES (2009) New directions in the epidemiology of schizophrenia. Med J Aust 190(4):S7–S9PubMed
34.
Zurück zum Zitat Menezes NM, Arenovich T, Zipursky RB (2006) A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med 36(10):1349–1362CrossRefPubMed Menezes NM, Arenovich T, Zipursky RB (2006) A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med 36(10):1349–1362CrossRefPubMed
35.
Zurück zum Zitat Menezes PR, Scazufca M, Busatto G et al (2007) Incidence of first-contact psychosis in Sao Paulo, Brazil. Br J Psychiatry 191:S102–S106CrossRef Menezes PR, Scazufca M, Busatto G et al (2007) Incidence of first-contact psychosis in Sao Paulo, Brazil. Br J Psychiatry 191:S102–S106CrossRef
36.
Zurück zum Zitat Morgan C, Kirkbride J, Hutchinson G et al (2008) Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study. Psychol Med 38:1701–1715CrossRefPubMed Morgan C, Kirkbride J, Hutchinson G et al (2008) Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study. Psychol Med 38:1701–1715CrossRefPubMed
37.
Zurück zum Zitat Munro CA, McCaul ME, Wong DF et al (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59(10):966–974CrossRefPubMed Munro CA, McCaul ME, Wong DF et al (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59(10):966–974CrossRefPubMed
38.
39.
Zurück zum Zitat Murray G, Clark L, Corlett P et al (2008) Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry 8(1):34CrossRefPubMed Murray G, Clark L, Corlett P et al (2008) Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry 8(1):34CrossRefPubMed
40.
Zurück zum Zitat Parks J, Radke A, Parker G et al (2008) Principles of antipsychotic prescribing for policy makers, Circa 2008. Translating knowledge to promote individualized treatment. Schizophr Bull, sbn019 Parks J, Radke A, Parker G et al (2008) Principles of antipsychotic prescribing for policy makers, Circa 2008. Translating knowledge to promote individualized treatment. Schizophr Bull, sbn019
41.
Zurück zum Zitat Passos Gregorio S, Gattaz WF, Tavares H et al (2006) Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects. Schizophr Res 88(1–3):275–282CrossRefPubMed Passos Gregorio S, Gattaz WF, Tavares H et al (2006) Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects. Schizophr Res 88(1–3):275–282CrossRefPubMed
42.
Zurück zum Zitat Patel MX, de Zoysa N, Bernadt M et al (2008) A cross-sectional study of patients’ perspectives on adherence to antipsychotic medication: depot versus oral. J Clin Psychiatry 69(10):1548–1556CrossRefPubMed Patel MX, de Zoysa N, Bernadt M et al (2008) A cross-sectional study of patients’ perspectives on adherence to antipsychotic medication: depot versus oral. J Clin Psychiatry 69(10):1548–1556CrossRefPubMed
43.
Zurück zum Zitat Patil ST, Zhang L, Martenyi F et al (2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 13(9):1102–1107CrossRefPubMed Patil ST, Zhang L, Martenyi F et al (2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 13(9):1102–1107CrossRefPubMed
44.
Zurück zum Zitat Sallet PC, Elkis H, Alves TM et al (2003) Reduced cortical folding in schizophrenia: an MRI morphometric study. Am J Psychiatry 160(9):1606–1613CrossRefPubMed Sallet PC, Elkis H, Alves TM et al (2003) Reduced cortical folding in schizophrenia: an MRI morphometric study. Am J Psychiatry 160(9):1606–1613CrossRefPubMed
45.
Zurück zum Zitat Selten JP, Cantor-Graae E (2005) Social defeat: risk factor for schizophrenia? Br J Psychiatry 187(2):101–102CrossRefPubMed Selten JP, Cantor-Graae E (2005) Social defeat: risk factor for schizophrenia? Br J Psychiatry 187(2):101–102CrossRefPubMed
46.
Zurück zum Zitat Stefani MR, Moghaddam B (2005) Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav Neurosci 119(2):420–428CrossRefPubMed Stefani MR, Moghaddam B (2005) Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav Neurosci 119(2):420–428CrossRefPubMed
47.
Zurück zum Zitat Stefansson H, Rujescu D, Cichon S et al (2008) Large recurrent microdeletions associated with schizophrenia. Nature 455(7210):232–236CrossRefPubMed Stefansson H, Rujescu D, Cichon S et al (2008) Large recurrent microdeletions associated with schizophrenia. Nature 455(7210):232–236CrossRefPubMed
48.
Zurück zum Zitat Tandon R, Belmaker RH, Gattaz WF et al (2008) World psychiatric association pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res 100(1–3):20–38CrossRefPubMed Tandon R, Belmaker RH, Gattaz WF et al (2008) World psychiatric association pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res 100(1–3):20–38CrossRefPubMed
49.
Zurück zum Zitat van Os J, Allardyce J (2009) The clinical epidemiology of schizophrenia. In: Kaplan B, Saddock J, Saddock V (eds) Comprehensive textbook of psychiatry. Williams and Wilkins, London van Os J, Allardyce J (2009) The clinical epidemiology of schizophrenia. In: Kaplan B, Saddock J, Saddock V (eds) Comprehensive textbook of psychiatry. Williams and Wilkins, London
50.
Zurück zum Zitat Veling W, Selten J-P, Susser E et al (2007) Discrimination and the incidence of psychotic disorders among ethnic minorities in The Netherlands. Int J Epidemiol 36(4):761–768CrossRefPubMed Veling W, Selten J-P, Susser E et al (2007) Discrimination and the incidence of psychotic disorders among ethnic minorities in The Netherlands. Int J Epidemiol 36(4):761–768CrossRefPubMed
51.
Zurück zum Zitat Veling W, Susser E, van Os J et al (2008) Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry 165(1):66–73CrossRefPubMed Veling W, Susser E, van Os J et al (2008) Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry 165(1):66–73CrossRefPubMed
52.
Zurück zum Zitat Walsh T, McClellan JM, McCarthy SE et al (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875):539–543CrossRefPubMed Walsh T, McClellan JM, McCarthy SE et al (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875):539–543CrossRefPubMed
53.
Zurück zum Zitat Xu B, Roos JL, Levy S et al (2008) Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40(7):880–885CrossRefPubMed Xu B, Roos JL, Levy S et al (2008) Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40(7):880–885CrossRefPubMed
54.
Zurück zum Zitat Zink CF, Tong Y, Chen Q et al (2008) Know your place: neural processing of social hierarchy in humans. Neuron 58(2):273–283CrossRefPubMed Zink CF, Tong Y, Chen Q et al (2008) Know your place: neural processing of social hierarchy in humans. Neuron 58(2):273–283CrossRefPubMed
Metadaten
Titel
Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3–6 February 2009
verfasst von
James Bowes Kirkbride
Linda Scoriels
Publikationsdatum
01.12.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 8/2009
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-009-0025-1

Weitere Artikel der Ausgabe 8/2009

European Archives of Psychiatry and Clinical Neuroscience 8/2009 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.